Análisis del concepto “Diabesidad”

Dannya de-la-Vega; Julisa Morquecho Nava; Octavio Isidro Pérez; Natalia Ramírez-Girón

doi:10.58807/indexenferm20225176

Dannya de-la-Vega Fundación Universidad de las Américas. Puebla, México https://orcid.org/0000-0002-2905-0525
Julisa Morquecho Nava Fundación Universidad de las Américas. Puebla, México https://orcid.org/0000-0003-3159-6399
Octavio Isidro Pérez Fundación Universidad de las Américas. Puebla, México https://orcid.org/0000-0001-7105-1065
Natalia Ramírez-Girón Fundación Universidad de las Américas. Puebla, México https://orcid.org/0000-0002-8312-6287

DOI: https://doi.org/10.58807/indexenferm20225176

Palabras clave: Diabesidad, Obesidad, Diabetes tipo 2

Key-words: Diabesity, Obesity, Type 2 diabetes

Resumen

Análisis del concepto diabesidad, mediante la metodología de Walker y Avant, los cuales proponen ocho pasos: (1) Selección del concepto: se seleccionó dada la carga global de morbi-mortalidad atribuida a la diabetes y obesidad. (2) Objetivo del análisis: reunir información sobre la diabesidad para tener una línea de base sobre la utilización e implicaciones del mismo. (3) Identificar los usos: se ha usado para designar simultáneamente a la obesidad y diabetes dentro de la salud pública. (4) Características y atributos del concepto: se identifican diversas características relacionadas con alteraciones en todos los sistemas corporales, especialmente en el metabólico. (5) Caso modelo y (6) Caso contrario/límite: ambos se realizaron con base en la literatura. (7) Identificación de antecedentes y consecuencias: dentro de los antecedentes se identifican los factores de riesgo cardiovascular y las consecuencias corresponden a las alternativas y tratamientos terapéuticos. (8) Definición de indicadores empíricos: se identificaron múltiples que contribuyen a medir diversas moléculas corporales relacionadas con obesidad y diabetes. Conclusión: La diabesidad es un padecimiento de alta prevalencia a nivel mundial, tiene repercusiones a nivel físico, psicológico y social, por tal motivo es importante la comprensión holística del fenómeno.

Abstract

Analysis of the concept of diabesity, through the methodology of Walker and Avant, who pro-pose eight steps. (1) Selection of the concept: it was selected given the global burden of morbidi-ty and mortality attributed to diabetes and obesity. (2) Aim of the analysis: gather information on diabesity to have a baseline on its use and implications. (3) Identify the uses: it has been used to simultaneously designate obesity and diabetes within public health. (4) Characteristics and at-tributes of the concept: various characteristics related to alterations in all body systems, especial-ly in the metabolic system, are identified. (5) Model case and (6) Opposite case/limit: it was car-ried out based on the literature. (7) Identification of antecedents and consequences: within the antecedents, cardiovascular risk factors are identified and the consequences correspond to thera-peutic alternatives and treatments. (8) Definition of empirical indicators: multiple indicators were identified that help measure various body molecules related to obesity and diabetes. Con-clusion: Diabesity is a disease of high prevalence worldwide, it has physical, psychological and social repercussions; For this reason, a holistic understanding of the phenomenon is important.

Bibliografía

1.Organización Mundial de la Salud. Obesidad y Sobrepeso. 2022. Disponible en: https://www.who. int/es/news-room/fact-sheets/detail/obesity-and-over weight [acceso: 23/05/2022].
2.Organización Mundial de la Salud. Diabetes. 2022. Disponible en: https://www.who.int/es/news-room/ fact-sheets/detail/diabetes [acceso: 23/05/2022].
3. Encuesta Nacional de Salud y Nutrición 2018. Disponible en: https://ensanut.insp.mx/encuestas/en sanut2018/doctos/informes/ensanut_2018_presentacion _resultados.pdfM [acceso: 23/05/2022].
4. Pajuelo Ramírez, Jaime; Torres Aparcana, Lizardo; Agüero Zamora, Rosa; Bernui Leo, Ivonne. El sobrepeso, la obesidad y la obesidad abdominal en la población adulta del Perú. Anales de la Facultad de Medicina 2019; 80(1): 21-27. Doi: https://dx.doi.org/ 10.15381/anales.v80i1.15863.
5. Walker, Lorraine; Avant, Kay. Strategies for theory construction in nursing. 5th ed. Upper Saddle River. 2011; NJ: Pearson Prentice Hall.
6. Cardoso, Susana; Moreira, Paula. Diabesity and brain disturbances: A metabolic perspective. Molecular aspects of medicine 2019; 66:71–79. Doi: https://doi.org/10.1016/j.mam.2018.10.002.
7. Assunta Potenza, Maria; Iacobazzi, Dominga; Sgarra, Luca; Montagnani, Monica. The Intrinsic Virtues of EGCG, an Extremely Good Cell Guardian, on Prevention and Treatment of Diabesity Complications. Molecules 2020; 25(13):3061. Doi: https://doi.org/10.3390/molecules25133061.
8. Ortega, Miguel; Fraile Martínez, Oscar; Naya, Irene; García Honduvilla, Natalio; Álvarez Mon, Melchor; Buján, Julián; Asúnsolo, Ángel; de la Torre, Basilio. Type 2 Diabetes Mellitus Associated with Obesity (Diabesity). The Central Role of Gut Microbiota and Its Translational Applications. Nutrients 2020; 12(9):2749. Doi: https://doi.org/10.3390/nu12092749.
9. Chawla, Rajeev; Shalini, Jaggi. Implications of CVD-REAL. Study for Indian diabetic population. J Diabetol. 2019; 10:57-61. Disponible en: https://bit.ly/3qx5W6x [acceso: 23/05/2022].
10. Leitner, Deborah; Frühbeck, Gema; Yumuk, Volkan; Schindler, Karin; Micic, Dragan; Woodward, Euan; Toplak, Hermann. Obesidad y diabetes tipo 2: dos enfermedades que necesitan estrategias de trata-miento combinadas: la EASO puede liderar el camino. Hechos sobre la obesidad 2017; 10(5):483–492. Doi: https://doi.org/10.1159/000480525.
11. Farzi, Aitak; Fröhlich, Esther; Holzer, Peter. Gut Microbiota and the Neuroendocrine Sytem. Neurother-apeutics: the journal of the American Society for Experimental Neuro Therapeutics. 2018;15(1):5–22. Doi: https://doi.org/10.1007/s13311-017-0600-5.
12. Colagiuri, Stephen. Diabesity: therapeutic options. Diabetes, obesity and metabolism. 2010;12(6):463–473. Doi: https://doi.org/10.1111/j.1463-1326.2009. 01182.x.
13.Villalobos Labra, Roberto; Subiabre, Mario; Toledo, Fernando; Pardo, Fabián Sobrevia, Luis. Endoplasmic reticulum stress and development of insulin resistance in adipose, skeletal, liver, and foetoplacental tissue in diabesity. Molecular aspects of medicine 2019; 66(1):49–61. Doi: https://doi.org/10.1016/j.mam. 2018.11.001.
14. Anjum, Qudsia. Diabesity a future pandemic. JPMA. The Journal of the Pakistan Medical Associa-tion 2011; 61(4):321. Disponible en: https://www. jpma.org.pk/PdfDownload/2690.pdf [acceso: 23/05/ 2022].
15. Cuschieri, Sarah; Vassallo, Josane; Calleja, Neville; Pace, Nikolai; Abela, Janice; Ali, Bader; Abdullah, Fatemath; Zahra, Elizier; Mamo, Julian. The diabesity health economic crisis-the size of the crisis in a European island state following a cross-sectional study. Archives of public health 2016; 74(1):52. Doi: https://doi.org/10.1186/s13690-016-0164-6.
16. Cardoso, Susana; Seiça, Raquel; Moreira, Paula. Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease. Advances in neurobiology 2017; 19:117–150. Doi: https://doi.org/10.1007/978-3-319-63260-5_5.
17. Thompson, Alan; Banwell, Brenda; Barkhof, Frederick; Carroll, William; Coetzee, Timothy; Comi, Giancarlo; et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. The Lancet. Neurology 2017; 17(2):162–173. Doi: https://doi.org/ 10.1016/S1474-4422(17)30470-2.
18. Tuttle, Lori; Bittel, Daniel; Bittel, Adam; Sinacore, David. Early-Onset Physical Frailty in Adults With Diabesity and Peripheral Neuropathy. Canadian Journal of Diabetes 2018; 42(5):478–483. Doi: https://doi. org/10.1016/j.jcjd.2017.12.001.
19. Morselli, Lisa; Leproult, Rachel; Balbo, Marcela; Spiegel, Karine. Role of sleep duration in the regulation of glucose metabolism and appetite. Best practice & research. Clinical Endocrinology & Metabolism. 2010; 24(5): 687–702. Doi: https://doi.org/10.1016/ j.beem.2010.07.005.
20. Hazman, Ömer; Aksoy, Laçine; Büyükben, Ahmet. Effects of crocin on experimental obesity and type-2 diabetes. Turkish journal of medical sciences 2015; 46(5): 1593–1602. Doi: https://doi.org/10.3906/sag-1506-108.
21. Alarcón, Sebastián; Niechi, Ignacio; Toledo, Fernando; Sobrevia, Luis; Quezada Claudia. Glioma progression in diabesity. Molecular aspects of medicine. 2019; 66:62–70. Doi: https://doi.org/ 10.1016/j.mam.2019.02.002.
22. Kalra, Sanjay. Diabesity. JPMA. The Journal of the Pakistan Medical Association. 2013; 63(4): 532–534. Disponible en: https://pubmed.ncbi.nlm.nih.gov/239 05459/ [acceso: 23/05/2022].
23. Gambino, Roberto; Musso, Giovanni; Cassader, Maurizio. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxidants & redox signaling 2013; 15(5): 1325–1365. Doi: https://doi.org/10.1089/ ars.2009.3058.
24. Toplak, Hermann; Leitner, Deborah; Harreiter, Jürgen; Hoppichler, Friedrich; Wascher, Thomas; Schindler, Karin; Ludvik, Bernhad. Diabesity Adiposi-tas und Typ-2-Diabetes (Update 2019). Wiener klinische Wochenschrift 2019; 131(Suppl 1), 71–76. Doi: https://doi.org/10.1007/s00508-018-1418-9.
25. Wells, Jonathan. The diabesity epidemic in the light of evolution: insights from the capacityload model. Diabetologia 2019; 62(10):1740–1750. Doi: https://doi.org/10.1007/s00125-019-4944-8.
26. Lazar, Verónica; Ditu, Lia; Pircalabioru, Gratiela; Picu, Ariana; Petcu, Lau; Cucu, Natalia; Chifiriuc, Mariana. Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity. Frontiers in Nutrition 2019; 6: 21. Doi. https://doi.org/10.3389/ fnut.2019.00021.
27. Burgio, Ernesto; Lopomo, Ángela; Migliore, Lucia. Obesity and diabetes: from genetics to epigenetics. Molecular Biology Reports 2014; 42(4):799–818. Doi: https://doi.org/10.1007/s11033-014-3751-z.
28. Núñez Cortés, Jesús; Pedro Botet, Juan. Atherogenic dyslipemia: the other pandemic, associated with diabesity. Dislipemia aterogénica: la otra pandemia, asociada a la diabesidad. Clínica e investigación en arteriosclerosis 2021; 33(1):30–32. Doi: https://doi.org/ 10.1016/j.arteri.2020.12.001.
29. Pincock, Sthephen. Paul Zimmet: fighting the "diabesity" pandemic. Lancet London, England. 2006; 368(9548): 1643. Doi: https://doi.org/10.1016/S0140-6736(06)69682-7.
30. Cameron, Erin; O'Reilly, Caitlin. Type 2 diabetes in youth. Biochemistry and cell biology = Biochimie et biologie cellulaire. 2015; 93(5):430–437. Doi: https://doi.org/10.1139/bcb-2014-0133.
31. Chauhan, Hiteshi. Diabesity: the 'Achilles Heel' of our modernized society. Revista da Associação Médica Brasileira 2012; 58(4):399. Doi: https://doi.org/10. 1590/S0104-42302012000400002.
32. Balakumaran, Janatani; Kao, Yun; Wang, Kuan; Ronen, Gabriel; MacKillop, James; Thabane, Lehana; Samaan, Constantine. Translating knowledge into action to prevent pediatric and adolescent diabesity: a meeting report. Adolescent health, medicine and therapeutics. 2019; 10: 91–10. Doi: https://doi.org/ 10.2147/AHMT.S209922.
33. Maninder, Meenua; Xu, Baojun. A critical review on antidiabetic and antiobesity effects of dietary resistant starch. Critical reviews in food science and nutrition 2018; 59(18): 3019–3031. Doi: https://doi. org/10.1080/10408398.2018.1481360.
34. Nagasaki, Hiroshi; Shang, Quinlong; Suzuki, Takeshi; Hashimoto, Hiroyuki; Yoshimura, Tomoko; Kondo, Taka; Ozaki, Takenori; Maruyama, Shouichi; Jomori, Takahito; Oiso, Yutaka; Hamada, Yoji. Lowserum culture system improves the adipogenic ability of visceral adipose tissue-derived stromal cells. Cell biology international 2013; 35(6): 559–568. Doi: https://doi.org/10.1042/CBI20100406.
35. Kiess, Wieland, Theresa Gorski, Melanie Penke, Sabine Klamt, Thomas M. Kapellen. Diabetes mellitus in children and adolescents – a global epidemic which has become neglected. Journal of Pediatric Endocrinology and Metabolism 2015; (28): 3-4. Doi: https://doi.org/10.1515/jpem-2015-0900.
36. Ayoub, Nour; Mantash, Hiba; Dhaini, Hassan; Mourad, Abbas; Hneino, Mohammad; Daher, Zeina. Serum Cadmium Levels and Risk of Metabolic Syndrome: A Cross-Sectional Study. Biological trace element research. 2021; 199:3625–3633. Doi: https://doi.org/10.1007/s12011-020-02502-3.
37. Ott, Patrick; Hu, Zhuting; Keskin, Derin; Shukla, Sachet; Sun, Jing; Bozym, David; et al. An immuno-genic personal neoantigen vaccine for patients with melanoma. Nature 2018; 547(7662): 217–221. Doi: https://doi.org/10.1038/nature22991.
38. Lima Martínez, Marco; Carrera Boada, Carlos; Madera Silva, Marialaura; Marín, Waleskha; Contreras, Miguel. COVID-19 y diabetes mellitus: una relación bidireccional. Clínica e investigación en arteriosclerosis 2020; 33(3):151-157. Doi: https://doi. org/10.1016/j.arteri.2020.10.001.
39. Arroyo, Kerbin; Kini, Subash; Harvey, John; Herron, Daniel. Surgical therapy for diabesity. The Mount Sinai Journal of Medicine 2010; 77(5):418–430. Doi: https://doi.org/10.1002/msj.20209.
40. Gupta, Lovely; Khandelwal, Deepak; Lal, Priti; Kalra, Sanjay; Dutta, Deep. Palaeolithic Diet in Diabesity and Endocrinopathies-A Vegan's Perspective. European endocrinology 2019; 15(2): 77–82. Doi: https://doi.org/10.17925/EE.2019.15.2.77.
41. Castro Martínez, Maria; Castillo Anaya, Viviana; Ochoa Aguilar, Abraham; Godínez Gutiérrez, Sergio. La metformina y sus aplicaciones actuales en la clínica. Med Int Mex 2014; 30(5): 562-574. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2014/mim145i.pdf [acceso: 23/05/2022].
42. Mate, Alfonso; Reyes-Goya; Santana-Garrido; Vázquez, Carmen. Lifestyle, Maternal Nutrition and Healthy Pregnancy. Current vascular pharmacology. 2021; 19(2): 132–140. Doi: https://doi.org/10.2174/ 1570161118666200401112955.
43. Landeros-Olvera, Erick; Ramirez-Giron, Natalia; Alba-Alba, Corina. Interacción de Genes Bio-Sociales en la Expresión de la Diabesidad. Salud y administración. 2022. Disponible en: https://revista.unsis.edu.mx/ in-dex.php/saludyadmon/article/view/236/179 [acceso: 23/05/2022].
44. Ng, Arnold; Delgado, Victoria; Borlaug, Barry; Bax, Jeroen. Diabesity: the combined burden of obesity and diabetes on heart disease and the role of imaging. Nat Rev Cardiol. 2021;18(4): 291-304. Doi: https://doi.org/10.1038/s41569-020-00465-5.
45. Guarisco, Gloria; Leonetti, Frida. Covid-19 and diabesity: when a pandemia cross another pandemia. Eat Weight Disord. 2021;26(5):1283-1286. Doi: https://doi.org/10.1007/s40519-020-00958-9.
46. Guevara Castro, Diana Laura; Blanco García, Samaria Sinaí; González Serrano, Juquila Anaís; de la Cruz Bernabé, Enrique Jair; Mendoza Catalán, Geu. Asociación del sueño con la diabesidad en adultos mexicanos. Index de Enfermería 2022; 31(1): 34-7. Disponible en: http://ciberindex.com/c/ie/e13347 [acceso: 16/08/2022].
47. Filgueiras de Assis Mello, Maria Virgínia; Ferreira de Andrade, Rosemary; Miyar Otero, Liudmila; Celis de Cárdenas, Anneli Mercedes; Rodrigues da Silva, Silvana. Factores de riesgo relacionados con la diabesidad en estudiantes de escuelas primarias en la región Amazónica de Brasil. Investigación y Educación en Enfermería. 2013; 31(3): 433-441. Disponible: https://bit.ly/3R0s8AY [acceso: 16/08/2022].

Análisis del concepto “Diabesidad”

“Diabesity” concept analysis

Resumen

Abstract

Bibliografía